EVO ICL Surgery: Implantable Vision Correction for Moderate to High Myopia
Patients with moderate or high myopia may be told that their prescription is outside the ideal range for LASIK, SMILE, or PRK. Others may have corneas that are too thin, irregular, or dry for corneal laser surgery.
EVO ICL offers a different approach. Instead of reshaping the cornea, it places a prescription lens inside the eye.
What Is an EVO ICL?
ICL stands for implantable collamer lens. EVO ICL is a type of phakic intraocular lens, meaning it is implanted without removing the eye’s natural lens.
The EVO ICL is positioned:
Behind the colored iris
In front of the natural crystalline lens
The implant adds focusing power inside the eye while the cornea and natural lens remain in place.
This is different from refractive lens exchange and cataract surgery, both of which remove the natural lens.
Who Is EVO ICL Designed For?
Current FDA labeling indicates EVO and EVO+ ICL for patients ages 21 through 45 with qualifying myopia. The approved range includes correction of myopia from approximately −3.00 through −15.00 diopters and reduction of myopia greater than −15.00 through −20.00 diopters, with specific astigmatism limitations. A toric version is available for qualifying myopic astigmatism.
A potential candidate generally needs:
A stable prescription
Adequate space in the front portion of the eye
A sufficiently open drainage angle
A healthy corneal endothelium
Healthy ocular structures
Realistic visual expectations
The evaluation typically includes anterior-chamber-depth measurements, endothelial cell counts, gonioscopy, refraction, pupil evaluation, corneal imaging, eye-pressure testing, and a dilated retinal examination. The FDA specifically emphasizes measuring the anterior chamber and corneal endothelial cells before phakic lens surgery.
Why Might Someone Choose EVO ICL?
Potential advantages include:
Treatment of higher levels of myopia
No removal of corneal tissue
No corneal flap
Preservation of the natural lens
A smaller effect on corneal shape
Possible future removal or replacement of the implant
Built-in ultraviolet protection in the lens material
The implant may be removable, but the procedure should not be described as completely reversible. Any surgery inside the eye can potentially produce permanent changes or complications.
What Happens During Surgery?
The eye is numbed, and the surgeon creates a small corneal incision. The folded ICL is inserted through the incision and positioned behind the iris.
The incision is often small enough to heal without stitches. One eye may be treated at a time, depending on the surgeon’s protocol.
Vision can improve quickly, but it may initially fluctuate because of dilation, inflammation, medication, or temporary changes in eye pressure.
What Are the Risks?
EVO ICL requires surgery inside the eye. Potential risks include:
Infection
Inflammation
Elevated eye pressure
Glaucoma
Cataract formation
Endothelial cell loss
Incorrect lens sizing or positioning
Excessively high or low vault over the natural lens
Glare, halos, or nighttime visual disturbances
Residual prescription
Need for repositioning, replacement, or removal
Retinal tears or retinal detachment
Rare loss of vision
FDA labeling includes minimum anterior-chamber and endothelial-cell requirements because insufficient space or inadequate endothelial health can increase the risk of complications.
Patients with high myopia already have a greater lifetime risk of retinal problems. A careful peripheral retinal examination is therefore important before surgery, and flashes, new floaters, or a curtain over the vision require urgent attention afterward.
EVO ICL Versus LASIK
LASIK changes the corneal curvature permanently. EVO ICL adds an internal prescription lens without removing corneal tissue.
LASIK may be more appropriate for lower prescriptions and eyes with excellent corneal measurements. EVO ICL may be preferable for higher myopia or when the cornea is not suitable for laser reshaping.
Because EVO ICL is intraocular surgery, its potential complications differ from those of LASIK.
EVO ICL Versus Refractive Lens Exchange
EVO ICL preserves the natural lens and its remaining ability to focus at near. Refractive lens exchange removes the natural lens permanently.
For a younger myopic patient with clear lenses and healthy internal eye measurements, preserving the natural lens may be an important advantage. For an older patient with presbyopia, early cataract, or significant farsightedness, lens replacement may make more sense.
EVO ICL Evaluations in Tampa
A consultation should evaluate both the front and back of the eye, not simply confirm the prescription.
At OPT-ISM Eye Care in Tampa, comprehensive testing can help determine whether EVO ICL, corneal laser surgery, or continued glasses and contact lenses provide the most appropriate balance of clarity, safety, and long-term eye health.
Comments